Back to search results

A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

Abroad (travel likely)RecruitingPHASE1

Conditions

ALS (Amyotrophic Lateral Sclerosis)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UZ Leuven, Leuven, Belgium

    Study coordinator · (321) 634-4280
    Contact: Principal Investigator (Philip Van Damme)

  • Heritage Medical Research Clinic, Calgary, Canada

    Study coordinator · 403-210-7006
    Contact: Principal Investigator (Theodore Mobach)

  • Walter Mackenzie Health Sciences Centre, Edmonton, Canada

    Study coordinator · 780.248.1089
    Contact: Principal Investigator (Peter Dobrowolski)

  • London Health Sciences Centre, London, Canada

    Study coordinator · 519-663-3597
    Contact: Principal Investigator (Christen Shoesmith)

  • Montreal Neurological Institute and Hospital, Montreal, Canada

    Study coordinator · 514-449-8741
    Contact: Principal Investigator (Angela Genge)

  • Sunnybrook Research Institute, Toronto, Canada

    Study coordinator · 4134806860
    Contact: Principal Investigator (Agessandro Abrahao)

  • Universitätsklinikum Schleswig-Holstein, Lübeck, Germany

    Study coordinator · 4936419323426
    Contact: Principal Investigator (Julian Grosskreutz)

  • Universitätsmedizin Rostock Sektion für Translationale Neurodegeneration "Albrecht Kossel" Klinik und Poliklinik für Neurologie, Rostock, Germany

    Study coordinator · 49 (0)381 494-9541
    Contact: Principal Investigator (Andreas Hermann)

  • Universitätsklinikum Ulm, Ulm, Germany

    Study coordinator · (497315) 006-3099
    Contact: Principal Investigator (Jochen Weishaupt)

  • Universitair Medisch Centrum Utrecht, Utrecht, Netherlands

    Study coordinator · 31887553204
    Contact: Principal Investigator (Leonard van den Berg)

  • Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Spain

    Study coordinator · +34 933359011 ext 8486
    Contact: Principal Investigator (Monica Povedano)

  • Hospital Universitari i Politecnic La Fe, Valencia, Spain

    Study coordinator · 34644490025
    Contact: Principal Investigator (Juan Francisco Vazquez Costa)
Study leads

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

View source on ClinicalTrials.gov(opens in a new tab)